{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:44:59Z","timestamp":1776761099807,"version":"3.51.2"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The rising incidence of neuroendocrine tumors (NETs) and delayed motherhood raise concerns about pregnancy outcomes and management, yet data remain scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This national cohort study, conducted through the GTE and RENATEN\u2013ENDOCAN networks, included 17 women with NETs who experienced 26 pregnancies, resulting in 27 births. Maternal and fetal outcomes were analyzed based on tumor status, presence of carcinoid syndrome, and treatments during pregnancy. Early postpartum tumor evolution was evaluated using mRECIST on CT scans at 1 and 6 months after delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median maternal age at first pregnancy was 31. Among women with resected localized NETs, 71.4% remained in remission post-pregnancy, while 28.6% experienced recurrence. In metastatic NETs, disease remained stable in 50% of cases, with 21.4% showing progression. Most progression was observed on 1-month postpartum scans. No worsening of carcinoid syndrome symptoms occurred. The overall cesarean rate was 16.7%, increasing to 25% in those with carcinoid syndrome. Live birth rates were high: 94.4% under surveillance and 91% under somatostatin analog (SSA) therapy. Intrauterine growth restriction rate was higher in patients receiving SSA therapy, while birth weight and length were not affected. No developmental issues were observed by age 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pregnancy is generally safe and successful in women with NETs. No major safety concerns were observed with SSA; however, these findings should be interpreted cautiously given the small sample size. Their use should remain individualized within a multidisciplinary approach, with early postpartum tumor assessment to optimize fetal and maternal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag061","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:46:19Z","timestamp":1775821579000},"page":"519-526","source":"Crossref","is-referenced-by-count":0,"title":["Neuroendocrine tumors and pregnancy: the French PregNET study"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9369-6389","authenticated-orcid":false,"given":"Laura","family":"Gerard","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Edouard Herriot University Hospital, Hospices Civils de Lyon , Lyon 69003 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Juin","sequence":"additional","affiliation":[{"name":"Department of Hepatogastroenterology, Lyon Sud University Hospital, Hospices Civils de Lyon , Lyon 69310 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-5471","authenticated-orcid":false,"given":"Marine","family":"Perrier","sequence":"additional","affiliation":[{"name":"Department of Hepatogastroenterology and Digestive Oncology, Reims University Hospital , Reims 51100 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Cadiot","sequence":"additional","affiliation":[{"name":"Department of Hepatogastroenterology and Digestive Oncology, Reims University Hospital , Reims 51100 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[{"name":"Endocrine Department, Claude Huriez Hospital, Lille Regional University Hospital , Lille 59000 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2545-1967","authenticated-orcid":false,"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[{"name":"Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy , Villejuif 94800 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lola Jade","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Endoscopy and Digestive Oncology, Cochin Hospital, Paris Cit\u00e9 University, APHP , Paris 75014 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-4588","authenticated-orcid":false,"given":"Catherine","family":"Lombard-Bohas","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Edouard Herriot University Hospital, Hospices Civils de Lyon , Lyon 69003 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Edouard Herriot University Hospital, Hospices Civils de Lyon , Lyon 69003 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-8340","authenticated-orcid":false,"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Endoscopy and Digestive Oncology, Cochin Hospital, Paris Cit\u00e9 University, APHP , Paris 75014 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"926","key":"2026042103512104500_lvag061-B1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/pmj.78.926.752","article-title":"Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure","volume":"78","author":"Abraham","year":"2002","journal-title":"Postgrad Med J."},{"key":"2026042103512104500_lvag061-B2","first-page":"525","article-title":"Tracheal carcinoid during pregnancy","volume":"45","author":"Yamamoto","year":"2004","journal-title":"J Cardiovasc Surg (Torino)."},{"issue":"3","key":"2026042103512104500_lvag061-B3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/1753495X16687700","article-title":"A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy","volume":"10","author":"Kevat","year":"2017","journal-title":"Obstet Med."},{"issue":"1","key":"2026042103512104500_lvag061-B4","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13465","article-title":"Neuroendocrine tumours and pregnancy: real-world data from an European Neuroendocrine Tumour Centre of excellence","volume":"37","author":"Ratnayake","year":"2025","journal-title":"J Neuroendocrinol."},{"issue":"11","key":"2026042103512104500_lvag061-B5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41416-019-0606-3","article-title":"Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013\u20132015","volume":"121","author":"Genus","year":"2019","journal-title":"Br J Cancer."},{"issue":"8","key":"2026042103512104500_lvag061-B6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/COC.0000000000000925","article-title":"A real-world study of the incidence and outcomes of early-onset well-differentiated neuroendocrine neoplasms","volume":"45","author":"Abdel-Rahman","year":"2022","journal-title":"Am J Clin Oncol."},{"key":"2026042103512104500_lvag061-B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100510","article-title":"Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: a retrospective, population-based study","volume":"23","author":"White","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2026042103512104500_lvag061-B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1241724","article-title":"Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms","volume":"14","author":"Yao","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"2026042103512104500_lvag061-B9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3332\/ecancer.2012.240","article-title":"Pregnant with metastatic neuroendocrine tumour of the ovary: what now?","volume":"6","author":"Pistilli","year":"2012","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"2026042103512104500_lvag061-B10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijoa.2008.10.005","article-title":"Carcinoid tumor and intravenous octreotide infusion during labor and delivery","volume":"18","author":"Le","year":"2009","journal-title":"Int J Obstet Anesth."},{"key":"2026042103512104500_lvag061-B11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/481823","article-title":"Spontaneous regression of a carcinoid tumor following pregnancy","volume":"2014","author":"Sewpaul","year":"2014","journal-title":"Case Rep Endocrinol."},{"issue":"3","key":"2026042103512104500_lvag061-B12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijoa.2009.01.009","article-title":"Anaesthetic management of a pregnant woman with carcinoid disease","volume":"18","author":"Woo","year":"2009","journal-title":"Int J Obstet Anesth."},{"issue":"10","key":"2026042103512104500_lvag061-B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2022.102509","article-title":"Results of the 2021 French National Perinatal Survey and trends in perinatal health in metropolitan France since 1995","volume":"51","author":"Le Ray","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod."},{"issue":"2","key":"2026042103512104500_lvag061-B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-0035-1544211","article-title":"Predictors of disease-free survival and recurrence in patients with resected bronchial carcinoid tumors","volume":"64","author":"Lee","year":"2016","journal-title":"Thorac Cardiovasc Surg."},{"issue":"11","key":"2026042103512104500_lvag061-B15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1001\/jamaoncol.2018.2428","article-title":"Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors","volume":"4","author":"Singh","year":"2018","journal-title":"JAMA Oncol."},{"issue":"5","key":"2026042103512104500_lvag061-B16","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/SLA.0000000000005809","article-title":"Recurring pancreatic neuroendocrine tumor: timing and pattern of recurrence, and current treatment","volume":"278","author":"Pulvirenti","year":"2023","journal-title":"Ann Surg."},{"issue":"2","key":"2026042103512104500_lvag061-B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/jamasurg.2025.5401","article-title":"Recurrence in patients with lymph node-negative pancreatic neuroendocrine tumors","volume":"161","author":"Ventin","year":"2026","journal-title":"JAMA Surg."},{"key":"2026042103512104500_lvag061-B18","first-page":"57","article-title":"The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 women","volume":"39","author":"Patrelli","year":"2012","journal-title":"Clin Exp Obstet Gynecol."},{"issue":"3","key":"2026042103512104500_lvag061-B19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1530\/ERC-12-0223","article-title":"Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients","volume":"20","author":"Hilfenhaus","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"2026042103512104500_lvag061-B20","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/MPA.0000000000000203","article-title":"Expression of estrogen-induced genes and estrogen receptor \u03b2 in pancreatic neuroendocrine tumors: implications for targeted therapy","volume":"43","author":"Estrella","year":"2014","journal-title":"Pancreas"},{"key":"2026042103512104500_lvag061-B21","first-page":"921","article-title":"Expression pattern of CDX2, estrogen and progesterone receptors in primary gastroenteropancreatic neuroendocrine tumors and metastases","volume":"36","author":"Zimmermann","year":"2016","journal-title":"Anticancer Res."},{"issue":"1","key":"2026042103512104500_lvag061-B22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ejendo\/lvae163","article-title":"Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors","volume":"192","author":"Wang","year":"2025","journal-title":"Eur J Endocrinol."},{"key":"2026042103512104500_lvag061-B23","first-page":"342","article-title":"Spontaneous regression of a bronchial carcinoid tumour following pregnancy","volume":"63","author":"Luosto","year":"1974","journal-title":"Ann Chir Gynaecol Fenn."},{"issue":"9","key":"2026042103512104500_lvag061-B24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1200\/OP.20.00077","article-title":"Multidisciplinary management of cancer during pregnancy","volume":"16","author":"Silverstein","year":"2020","journal-title":"JCO Oncol Pract."},{"issue":"14","key":"2026042103512104500_lvag061-B25","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.3390\/jcm11143983","article-title":"Effect of neuroendocrine neoplasm treatment on human reproductive health and sexual function","volume":"11","author":"Zamponi","year":"2022","journal-title":"J Clin Med."},{"issue":"11","key":"2026042103512104500_lvag061-B26","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/RLU.0000000000002267","article-title":"Pregnancy and delivery after PRRT without sequelae","volume":"43","author":"Zhang","year":"2018","journal-title":"Clin Nucl Med."},{"issue":"1","key":"2026042103512104500_lvag061-B27","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-16-1059","article-title":"Management of endocrine disease: acromegaly and pregnancy: a contemporary review","volume":"177","author":"Abucham","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2026042103512104500_lvag061-B28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000471880","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms: systemic therapy\u2014biotherapy and novel targeted agents","volume":"105","author":"Pavel","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2026042103512104500_lvag061-B29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13023-021-01799-0","article-title":"Currarino syndrome: a comprehensive genetic review of a rare congenital disorder","volume":"16","author":"Dworschak","year":"2021","journal-title":"Orphanet J Rare Dis."},{"issue":"11","key":"2026042103512104500_lvag061-B30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1023\/a:1011016706969","article-title":"Epidemiologic characteristics of kidney malformations","volume":"16","author":"Harris","year":"2000","journal-title":"Eur J Epidemiol."},{"issue":"9","key":"2026042103512104500_lvag061-B31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJM199508313330918","article-title":"Maternal-fetal transfer of octreotide","volume":"333","author":"Caron","year":"1995","journal-title":"N Engl J Med."},{"issue":"5","key":"2026042103512104500_lvag061-B32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-2265.2009.03706.x","article-title":"Effects of octreotide exposure during pregnancy in acromegaly","volume":"72","author":"Maffei","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2026042103512104500_lvag061-B33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1210\/jcem.82.1.3714","article-title":"Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide","volume":"82","author":"Caron","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2026042103512104500_lvag061-B34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/BF03345293","article-title":"Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide","volume":"27","author":"Boulanger","year":"2004","journal-title":"J Endocrinol Invest."},{"issue":"10","key":"2026042103512104500_lvag061-B35","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1210\/jc.2009-2331","article-title":"Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women","volume":"95","author":"Caron","year":"2010","journal-title":"J Clin Endocrinol Metab."}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag061\/68033582\/lvag061.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/4\/519\/68033582\/lvag061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/4\/519\/68033582\/lvag061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:51:30Z","timestamp":1776757890000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/4\/519\/8651693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag061","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,4]]}}}